Purification, crystallization and preliminary X-ray analysis of IMP-18, a class B carbapenemase from Pseudomonas

Takamitsu Furuyama1, Yoshikazu Ishii, Norimasa Ohya

  • 1Department of Material and Biological Chemistry, Graduate School of Science and Engineering, Yamagata University, 1-4-12 Kojirakawa, Yamagata 990-8560, Japan.

Insights

This study focused on IMP-18, a metallo-β-lactamase (MBL) from Pseudomonas aeruginosa. Researchers determined its crystal structure to understand its function in hydrolyzing critical antibiotics.

Area of Science:

  • Structural Biology
  • Microbiology
  • Biochemistry

Background:

  • Class B β-lactamases, or metallo-β-lactamases (MBLs), are enzymes capable of hydrolyzing a broad spectrum of β-lactam antibiotics, including carbapenems.
  • The emergence of MBLs poses a significant threat to infectious disease treatment due to their resistance to existing β-lactamase inhibitors.
  • IMP-18 is a notable MBL identified in Pseudomonas aeruginosa, necessitating structural and functional characterization.

Purpose of the Study:

  • To elucidate the three-dimensional structure of the IMP-18 metallo-β-lactamase.
  • To provide insights into the catalytic mechanism and substrate specificity of IMP-18.
  • To facilitate the development of novel inhibitors targeting MBLs.

Main Methods:

  • Overexpression and purification of the IMP-18 enzyme from cloned Pseudomonas aeruginosa.
  • Crystallization of purified IMP-18 using vapor diffusion techniques.
  • X-ray crystallographic analysis of the IMP-18 crystals to determine the structure.

Main Results:

  • The IMP-18 crystal diffracted X-rays to a resolution of 2.4 Å.
  • The crystal belonged to the tetragonal space group P4(1)2(1)2.
  • Unit-cell parameters were determined as a = b = 120.77 Å and c = 96.54 Å, indicating two molecules per asymmetric unit.

Conclusions:

  • The determined crystal structure provides a high-resolution model of IMP-18.
  • The structural data will be crucial for understanding the molecular basis of IMP-18 activity.
  • This work lays the foundation for structure-based drug design against carbapenem-resistant bacteria.

Related Concept Videos